EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 172 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.91 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $38,836 | -73.8% | 1,998 | -61.8% | 0.00% | – |
| Q1 2023 | $148,262 | -90.7% | 5,226 | -81.7% | 0.00% | -100.0% |
| Q2 2019 | $1,589,000 | -56.0% | 28,534 | -37.6% | 0.01% | -60.0% |
| Q2 2017 | $3,609,000 | +720.2% | 45,750 | +303.3% | 0.02% | +566.7% |
| Q2 2016 | $440,000 | -94.6% | 11,344 | -94.3% | 0.00% | -95.2% |
| Q1 2016 | $8,093,000 | – | 199,831 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 112,666 | $1,777 | 0.65% |
| Smith, Graham & Co., Investment Advisors, LP | 273,099 | $4,306,771 | 0.54% |
| BRANDES INVESTMENT PARTNERS, LP | 1,134,363 | $17,888,904 | 0.35% |
| TANG CAPITAL MANAGEMENT LLC | 118,857 | $1,874,375 | 0.26% |
| Virtus Investment Advisers, Inc. | 20,867 | $329,073 | 0.22% |
| DENALI ADVISORS LLC | 32,300 | $509,371 | 0.18% |
| Nebula Research & Development LLC | 11,473 | $180,929 | 0.10% |
| SCOUT INVESTMENTS, INC. | 131,192 | $1,995,430 | 0.05% |
| XTX Topco Ltd | 15,050 | $237,339 | 0.04% |
| PDT Partners, LLC | 19,745 | $311,379 | 0.04% |